The Effect of Cryotherapy on Breast Cancer Patients - Trial NCT06020222
Access comprehensive clinical trial information for NCT06020222 through Pure Global AI's free database. This phase not specified trial is sponsored by Kaohsiung Medical University Chung-Ho Memorial Hospital and is currently Recruiting. The study focuses on Chemotherapy-induced Peripheral Neuropathy. Target enrollment is 94 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Kaohsiung Medical University Chung-Ho Memorial Hospital
Timeline & Enrollment
N/A
May 01, 2023
Dec 31, 2024
Primary Outcome
Patient neurotoxicity questionnaire (PNQ),Patient neurotoxicity questionnaire (PNQ),Patient neurotoxicity questionnaire (PNQ),Patient neurotoxicity questionnaire (PNQ),Patient neurotoxicity questionnaire (PNQ)
Summary
The goal of this clinical trial is to test the effect of cryotherpay on chemotherapy-induced
 peripheral neuropathy(CIPN) among Breast Cancer Patients. The main questions of research are:
 
 - Does cryotherapy reduce the incidence of CIPN?
 
 - Does cryotherapy reduce the severity of CIPN and improve the quality of life?
 Participants will be put on the cold gloves and boots during chemotherapy injection
 process and total 90 minutes.
 
 If there is a comparison group: Researchers will compare usual care group to make sure if it
 effects of CIPN.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06020222
Device Trial